Introduction: Colorectal cancer (CRC) screening reduces cancer incidence and mortality, but participation rates are suboptimal in the USA and associated with inequities in CRC outcomes for lower income and many racial/ethnic minoritised groups. A novel, US Food and Drug Administration-approved cell-free tumour DNA (cfDNA) blood test has the potential to improve screening rates, but the impact of offering this test on participation, including among populations at disproportionately increased risk for inequities in CRC outcomes, has not been studied. We designed a small effectiveness randomised controlled trial (RCT) comparing a strategy of offering expanded options for CRC screening including a cfDNA test to a strategy of standard usual care options for screening. Methods and analysis: This study is a two-arm, parallel-group RCT, with 1:1 randomisation of 340 patients to an intervention group versus a usual care group for CRC screening. Participants will include patients who are aged 45–75, not up-to-date with CRC screening and attending a routine primary care visit at Family Health Centers of San Diego, a Federally Qualified Health Center (FQHC) system serving a racial and ethnically diverse, low-income patient population. The intervention group will be offered choice of colonoscopy, at home faecal immunochemical test (FIT) or a combination of in clinic cfDNA and at home FIT. The usual care group will be offered a choice of colonoscopy or at home FIT. Both groups will receive education on the importance of screening and reminders to complete testing. Primary outcome is CRC screening completion within 60 days of enrolment, summarised as the proportion of all patients randomised by group, compared via a χ 2 test of proportions. Secondary outcomes will include: number of abnormal results for each test modality, test results, number of patients with abnormal tests referred for abnormal test follow-up, and number of patients who completed colonoscopy within 90 days of an abnormal non-invasive test result. Ethics and dissemination: This study was approved by the University of California, San Diego Office of Institutional Review Board Administration (811489). A waiver of documented (signed) consent was approved by and will allow for a pragmatic design that mimics usual care, in which all patients will be offered all options for CRC screening. Main results will be disseminated to trial participants via reporting of test results and study publication. Trial registration number: NCT06929481 .
Background: Empathy, compassion, self-compassion, and resilience are essential to medical practice and education. While some evidence shows that these traits may decline during medical school, few studies have examined all these capacities in the same cohorts or trends within an academic year. This study examines first-year longitudinal findings on cohort and within-year changes in these constructs among medical students. Methods: 98 students (58.2% female; MS1 25.5%, MS2 25.5%, MS3 20.4%, MS4 26.5%) from a large West Coast school participated in at least one wave of an online survey distributed 4 times during the 2023-2024 academic year. Validated measures assessed empathy (IRI), compassion (SCBCS), self-compassion (Neff SCS), and resilience (CD-RISC-10). Linear Mixed Models analyzed between-cohort differences over time with gender and race/ethnicity as covariates. Results: Compared to MS4 students, MS2 and MS3 students had significantly lower cognitive empathy and self-compassion, with marginally lower compassion and higher resilience (p = 0.06). Women reported higher compassion toward others but lower self-compassion and resilience than men. Conclusions: Lower empathy and compassion were observed as early as the second year of medical school, suggesting erosion factors, such as academic pressure and standardized testing, may impact trainees earlier than previously reported.
Background: Empathy, compassion, self-compassion, and resilience are essential to medical practice and education. While some evidence shows that these traits may decline during medical school, few studies have examined all these capacities in the same cohorts or trends within an academic year. This study examines first-year longitudinal findings on cohort and within-year changes in these constructs among medical students. Methods: 98 students (58.2% female; Mage = 26.34 (2.86); 37.8% White; MS1 25.5%, MS2 25.5%, MS3 20.4%, MS4 26.5%) from a large US school participated in at least one wave of an online survey distributed 4 times during the 2023–2024 academic year. Validated measures assessed empathy (IRI), compassion (SCBCS), self-compassion (Neff SCS), and resilience (CD-RISC-10). Linear mixed models analyzed between-cohort differences over time with gender and race/ethnicity as covariates. Results: Compared to MS4 students, MS2 and MS3 students had significantly lower cognitive empathy and self-compassion, with marginally lower compassion and higher resilience (p = 0.06). Women reported higher compassion toward others but lower self-compassion and resilience than men. Conclusions: Lower empathy and compassion were observed as early as the second year of medical school, suggesting erosion factors, such as academic pressure and standardized testing, may impact trainees earlier than previously reported.
17 February 2025 in Alimentary Pharmacology & Therapeutics
Viral infections have been associated with the development of achalasia. A 43-year-old woman presented with 2 weeks of dysphagia. Medical history was notable for oral herpes, shingles, and recent COVID-19 infection. Her physical examination was unremarkable. A barium esophagram suggested esophageal dysmotility. Her symptoms did not respond to botulinum toxin injections and dilation of the esophagus. Achalasia type II was diagnosed via high-resolution esophageal manometry, and peroral endoscopic myotomy was performed with resolution of her symptoms. This case adds to the literature and highlights the need to further explore the pathophysiological link between viruses and achalasia.